Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis

Iqbal, Javeed; Shen, Yulei; Liu, Yanyan; Fu, Kai; Jaffe, Elaine S.; Liu, Cuiling; Liu, Zhongfeng; Lachel, Cynthia M.; Deffenbacher, Karen; Greiner, Timothy C.; Vose, Julie M.; Bhagavathi, Sharathkumar; Staudt, Louis M.; Rimsza, Lisa; Rosenwald, Andreas; Ott, German; Delabie, Jan; Campo, Elias; Braziel, Rita M.; Cook, James R.; Tubbs, Raymond R.; Gascoyne, Randy D.; Armitage, James O.; Weisenburger, Dennis D.; McKeithan, Timothy W.; and Chan, Wing C., "Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis" (2012). Public Health Resources. 177. https://digitalcommons.unl.edu/publichealthresources/177

[1]  N. Rajewsky,et al.  MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb , 2007, Cell.

[2]  L. Staudt,et al.  The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation , 2012, Leukemia.

[3]  R. Iozzo,et al.  The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. , 2012, Blood.

[4]  Y. Akao,et al.  MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. , 2011, Cancer letters.

[5]  P. Linsley,et al.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.

[6]  Ming Yi,et al.  Human glioma growth is controlled by microRNA-10b. , 2011, Cancer research.

[7]  A. Wiestner,et al.  Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. , 2011, Blood.

[8]  R. Elkon,et al.  A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility , 2010, Nature Cell Biology.

[9]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[10]  L. Staudt,et al.  Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. , 2010, Blood.

[11]  J. Nevins,et al.  Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate. , 2010, Cancer research.

[12]  J. Cigudosa,et al.  Mantle cell lymphoma: transcriptional regulation by microRNAs , 2010, Leukemia.

[13]  P. Jin,et al.  Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. , 2010, Cell stem cell.

[14]  Tint Lwin,et al.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. , 2010, Blood.

[15]  A. Rosenwald,et al.  Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. , 2010, Cancer research.

[16]  W. Chan,et al.  Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. , 2010, Blood.

[17]  L. Staudt,et al.  SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype , 2009, Haematologica.

[18]  E. Montserrat,et al.  Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. , 2009, Blood.

[19]  A. Rosenwald,et al.  MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. , 2009, Cancer research.

[20]  B. Kroesen,et al.  miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes , 2009, Laboratory Investigation.

[21]  Dereje D. Jima,et al.  Patterns of microRNA expression characterize stages of human B-cell differentiation. , 2009, Blood.

[22]  W. Klapper,et al.  GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma , 2009, British journal of haematology.

[23]  E. Hoster,et al.  Improvement of overall survival in advanced stage mantle cell lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[25]  Supplemental Figure legend , 2009 .

[26]  R. Lai,et al.  Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. , 2008, Blood.

[27]  L. Staudt,et al.  Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.

[28]  Reuven Agami,et al.  Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. , 2008, Cancer research.

[29]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[30]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[31]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[32]  S. Landais,et al.  Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. , 2007, Cancer research.

[33]  L. Staudt,et al.  Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Staudt,et al.  Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. , 2005, Blood.

[36]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[38]  R. Tibshirani,et al.  Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data , 2004, PLoS biology.

[39]  T. Kipps,et al.  Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Bradley,et al.  Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. , 2003, Cancer cell.

[41]  D. Catovsky,et al.  A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. , 2003, Blood.

[42]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[43]  M. Radmacher,et al.  Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.

[44]  H. Niwa,et al.  Wnt Signaling Regulates Hemopoiesis Through Stromal Cells , 2001 .

[45]  R Grosschedl,et al.  Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. , 2000, Immunity.

[46]  A. López-Guillermo,et al.  Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. , 1999, Blood.

[47]  E. Clark,et al.  Cultured human follicular dendritic cells. Growth characteristics and interactions with B lymphocytes. , 1992, Journal of immunology.

[48]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.